Pulse Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,236	792	1,034	610	96	386
Market Cap Growth	-14.77%	-23.39%	69.60%	532.11%	-74.99%	-21.94%
Enterprise Value	1,174	718	966	573	102	360
Last Close Price	21.00	11.80	17.00	11.30	2.44	13.10
PS Ratio	4146.76	2658.43	-	-	147.32	309.48
PB Ratio	17.99	11.54	9.32	15.20	-45.87	12.30
P/TBV Ratio	18.78	12.04	9.66	16.99	-	14.78
EV/Sales Ratio	-	2408.93	-	-	156.14	288.38
Debt / Equity Ratio	0.09	0.09	0.08	0.21	-33.79	0.32
Net Debt / Equity Ratio	-0.91	-0.91	-0.95	-0.79	-6.59	-0.49
Net Debt / EBITDA Ratio	0.97	0.97	1.98	0.83	-0.26	0.28
Net Debt / FCF Ratio	1.35	1.35	2.99	1.06	-0.31	0.32
Asset Turnover	0.00	0.00	-	-	0.01	0.03
Quick Ratio	10.23	10.23	11.74	6.61	10.22	3.37
Current Ratio	10.53	10.53	11.88	6.76	10.39	4.30
Return on Equity (ROE)	-74.45%	-74.45%	-67.31%	-200.46%	-349.89%	-217.33%
Return on Assets (ROA)	-42.37%	-42.37%	-36.70%	-39.75%	-54.93%	-82.44%
Return on Capital Employed (ROCE)	-88.80%	-88.80%	-46.00%	-83.10%	-80.80%	-137.80%
Earnings Yield	-5.01%	-7.82%	-5.00%	-6.26%	-56.73%	-14.51%
FCF Yield	-3.75%	-5.85%	-3.40%	-4.92%	-45.98%	-12.43%
Buyback Yield / Dilution	-15.41%	-15.41%	-17.41%	-46.56%	-21.35%	-20.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.